↓ Skip to main content

Graphene Oxide-Gallic Acid Nanodelivery System for Cancer Therapy

Overview of attention for article published in Nanoscale Research Letters, November 2016
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
60 Dimensions

Readers on

mendeley
86 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Graphene Oxide-Gallic Acid Nanodelivery System for Cancer Therapy
Published in
Nanoscale Research Letters, November 2016
DOI 10.1186/s11671-016-1712-2
Pubmed ID
Authors

Dena Dorniani, Bullo Saifullah, Farahnaz Barahuie, Palanisamy Arulselvan, Mohd Zobir Bin Hussein, Sharida Fakurazi, Lance J. Twyman

Abstract

Despite the technological advancement in the biomedical science, cancer remains a life-threatening disease. In this study, we designed an anticancer nanodelivery system using graphene oxide (GO) as nanocarrier for an active anticancer agent gallic acid (GA). The successful formation nanocomposite (GOGA) was characterized using XRD, FTIR, HRTEM, Raman, and UV/Vis spectroscopy. The release study shows that the release of GA from the designed anticancer nanocomposite (GOGA) occurs in a sustained manner in phosphate-buffered saline (PBS) solution at pH 7.4. In in vitro biological studies, normal fibroblast (3T3) and liver cancer cells (HepG2) were treated with different concentrations of GO, GOGA, and GA for 72 h. The GOGA nanocomposite showed the inhibitory effect to cancer cell growth without affecting normal cell growth. The results of this research are highly encouraging to go further for in vivo studies.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 86 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 86 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 14 16%
Researcher 11 13%
Student > Ph. D. Student 11 13%
Student > Bachelor 10 12%
Student > Doctoral Student 5 6%
Other 11 13%
Unknown 24 28%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 11 13%
Chemistry 10 12%
Materials Science 8 9%
Pharmacology, Toxicology and Pharmaceutical Science 6 7%
Chemical Engineering 5 6%
Other 18 21%
Unknown 28 33%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 October 2022.
All research outputs
#14,558,031
of 23,314,015 outputs
Outputs from Nanoscale Research Letters
#449
of 1,091 outputs
Outputs of similar age
#180,062
of 314,313 outputs
Outputs of similar age from Nanoscale Research Letters
#10
of 16 outputs
Altmetric has tracked 23,314,015 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,091 research outputs from this source. They receive a mean Attention Score of 3.2. This one has gotten more attention than average, scoring higher than 58% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 314,313 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.